Chronic obstructive pulmonary disease prognostic score: A new index

The evaluation of chronic obstructive pulmonary disease (COPD) has been shifting from spirometry to focus on the patients' overall health. Despite the existence of many COPD prognostic scales, there remains a large gap for improvement, in particular a scale that incorporates the current focus o...

Full description

Saved in:
Bibliographic Details
Published in:Biomedical papers of the Medical Faculty of the University Palacký, Olomouc, Czechoslovakia Vol. 160; no. 2; pp. 211 - 218
Main Authors: Horita, Nobuyuki, Koblizek, Vladimir, Plutinsky, Marek, Novotna, Barbora, Hejduk, Karel, Kaneko, Takeshi
Format: Journal Article
Language:English
Published: Czech Republic Palacký University Olomouc, Faculty of Medicine and Dentistry 01-06-2016
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Abstract The evaluation of chronic obstructive pulmonary disease (COPD) has been shifting from spirometry to focus on the patients' overall health. Despite the existence of many COPD prognostic scales, there remains a large gap for improvement, in particular a scale that incorporates the current focus on overall health. We proposed a new prognostic scale (the COPD Prognostic Score) through discussion among the authors based on published studies. Validation was retrospective, using data from the National Emphysema Treatment Trial. The scores ranged from 0-16, where 16 indicated the poorest prognosis. We assigned 4 points each for forced expiratory volume in one second (%predicted), the modified Medical Research Council dyspnea scale, and age; 2 points for the hemoglobin level; and one point each for decreased activity and respiratory emergency admission in the last two years. The validation cohort included 607 patients and consisted of 388 men (73.9%) and 219 women (36.1%), mean age 67 ± 6 years and an average forced expiratory volume in one second (% predicted) of 27 ± 7%. A one-point increase in the score was associated with increased all-cause death, with a hazard ratio of 1.28 (95%CI: 1.21-1.36. P < 0.001). The areas under the receiver operating characteristic curves for two-year and five-year all-cause death for the new scale were 0.72 and 0.66, respectively. These values were higher than those given by the body mass index, airflow obstruction, dyspnea, and exercise capacity (BODE) index and age, dyspnea, airway obstruction (ADO) index. The preliminary validation for a new COPD prognostic scale: the COPD Prognostic Score was developed with promising results thus far. Above mentioned 16-point score accurately predicted 2-year and 5-year all-cause mortality among subjects who suffered from severe and very severe COPD.
AbstractList Background: The evaluation of chronic obstructive pulmonary disease (COPD) has been shifting from spirometry to focus on the patients' overall health. Despite the existence of many COPD prognostic scales, there remains a large gap for improvement, in particular a scale that incorporates the current focus on overall health. Methods: We proposed a new prognostic scale (the COPD Prognostic Score) through discussion among the authors based on published studies. Validation was retrospective, using data from the National Emphysema Treatment Trial. Results: The scores ranged from 0-16, where 16 indicated the poorest prognosis. We assigned 4 points each for forced expiratory volume in one second (%predicted), the modified Medical Research Council dyspnea scale, and age; 2 points for the hemoglobin level; and one point each for decreased activity and respiratory emergency admission in the last two years. The validation cohort included 607 patients and consisted of 388 men (73.9%) and 219 women (36.1%), mean age 67 ± 6 years and an average forced expiratory volume in one second (% predicted) of 27 ± 7%. A one-point increase in the score was associated with increased all-cause death, with a hazard ratio of 1.28 (95%CI: 1.21-1.36. P < 0.001). The areas under the receiver operating characteristic curves for two-year and five-year all-cause death for the new scale were 0.72 and 0.66, respectively. These values were higher than those given by the body mass index, airflow obstruction, dyspnea, and exercise capacity (BODE) index and age, dyspnea, airway obstruction (ADO) index. Conclusion: The preliminary validation for a new COPD prognostic scale: the COPD Prognostic Score was developed with promising results thus far. Above mentioned 16-point score accurately predicted 2-year and 5-year all-cause mortality among subjects who suffered from severe and very severe COPD.
BACKGROUNDThe evaluation of chronic obstructive pulmonary disease (COPD) has been shifting from spirometry to focus on the patients' overall health. Despite the existence of many COPD prognostic scales, there remains a large gap for improvement, in particular a scale that incorporates the current focus on overall health.METHODSWe proposed a new prognostic scale (the COPD Prognostic Score) through discussion among the authors based on published studies. Validation was retrospective, using data from the National Emphysema Treatment Trial.RESULTSThe scores ranged from 0-16, where 16 indicated the poorest prognosis. We assigned 4 points each for forced expiratory volume in one second (%predicted), the modified Medical Research Council dyspnea scale, and age; 2 points for the hemoglobin level; and one point each for decreased activity and respiratory emergency admission in the last two years. The validation cohort included 607 patients and consisted of 388 men (73.9%) and 219 women (36.1%), mean age 67 ± 6 years and an average forced expiratory volume in one second (% predicted) of 27 ± 7%. A one-point increase in the score was associated with increased all-cause death, with a hazard ratio of 1.28 (95%CI: 1.21-1.36. P < 0.001). The areas under the receiver operating characteristic curves for two-year and five-year all-cause death for the new scale were 0.72 and 0.66, respectively. These values were higher than those given by the body mass index, airflow obstruction, dyspnea, and exercise capacity (BODE) index and age, dyspnea, airway obstruction (ADO) index.CONCLUSIONThe preliminary validation for a new COPD prognostic scale: the COPD Prognostic Score was developed with promising results thus far. Above mentioned 16-point score accurately predicted 2-year and 5-year all-cause mortality among subjects who suffered from severe and very severe COPD.
The evaluation of chronic obstructive pulmonary disease (COPD) has been shifting from spirometry to focus on the patients' overall health. Despite the existence of many COPD prognostic scales, there remains a large gap for improvement, in particular a scale that incorporates the current focus on overall health. We proposed a new prognostic scale (the COPD Prognostic Score) through discussion among the authors based on published studies. Validation was retrospective, using data from the National Emphysema Treatment Trial. The scores ranged from 0-16, where 16 indicated the poorest prognosis. We assigned 4 points each for forced expiratory volume in one second (%predicted), the modified Medical Research Council dyspnea scale, and age; 2 points for the hemoglobin level; and one point each for decreased activity and respiratory emergency admission in the last two years. The validation cohort included 607 patients and consisted of 388 men (73.9%) and 219 women (36.1%), mean age 67 ± 6 years and an average forced expiratory volume in one second (% predicted) of 27 ± 7%. A one-point increase in the score was associated with increased all-cause death, with a hazard ratio of 1.28 (95%CI: 1.21-1.36. P < 0.001). The areas under the receiver operating characteristic curves for two-year and five-year all-cause death for the new scale were 0.72 and 0.66, respectively. These values were higher than those given by the body mass index, airflow obstruction, dyspnea, and exercise capacity (BODE) index and age, dyspnea, airway obstruction (ADO) index. The preliminary validation for a new COPD prognostic scale: the COPD Prognostic Score was developed with promising results thus far. Above mentioned 16-point score accurately predicted 2-year and 5-year all-cause mortality among subjects who suffered from severe and very severe COPD.
Author Hejduk, Karel
Koblizek, Vladimir
Kaneko, Takeshi
Novotna, Barbora
Plutinsky, Marek
Horita, Nobuyuki
Author_xml – sequence: 1
  givenname: Nobuyuki
  surname: Horita
  fullname: Horita, Nobuyuki
  organization: Department of Pulmonology, Yokohama City University Graduate School of Medicine, Yokohama, Japan
– sequence: 2
  givenname: Vladimir
  surname: Koblizek
  fullname: Koblizek, Vladimir
  organization: Department of Pneumology, Faculty of Medicine in Hradec Kralove, Charles University in Prague and University Hospital Hradec Kralove, Hradec Kralove, Czech Republic
– sequence: 3
  givenname: Marek
  surname: Plutinsky
  fullname: Plutinsky, Marek
  organization: Department of Pneumology, University Hospital Brno and Faculty of Medicine, Masaryk University, Brno, Czech Republic
– sequence: 4
  givenname: Barbora
  surname: Novotna
  fullname: Novotna, Barbora
  organization: Department of Pneumology, Faculty of Medicine in Hradec Kralove, Charles University in Prague and University Hospital Hradec Kralove, Hradec Kralove, Czech Republic
– sequence: 5
  givenname: Karel
  surname: Hejduk
  fullname: Hejduk, Karel
  organization: Institute of Biostatistics and Analyses, Faculty of Medicine, Masaryk University, Brno, Czech Republic
– sequence: 6
  givenname: Takeshi
  surname: Kaneko
  fullname: Kaneko, Takeshi
  organization: Department of Pulmonology, Yokohama City University Graduate School of Medicine, Yokohama, Japan
BackLink https://www.ncbi.nlm.nih.gov/pubmed/27364317$$D View this record in MEDLINE/PubMed
BookMark eNo9kUlPwzAQhS1UxH7ijnJEQin2eEu5VRWbhMQFzpZjTyAojYudsPx7DC09zWj06c2beYdk0oceCTlldCol1Zf1agqUqSnldIccsIqKUktgk9wD42XFWLVPDlN6o1QBMLFH9kFzJTjTB2SxeI2hb10R6jTE0Q3tBxarsVuG3sbvwrcJbcqTGF76kIYMJhciXhXzosfPou09fh2T3cZ2CU829Yg831w_Le7Kh8fb-8X8oXR8BkM5A4fCaz_TAhkDp4FKWwnJNVjvUQjhVdN45RvtQVoQshIKHK0xX1czwY_I_VrXB_tmVrFdZosm2Nb8DUJ8MTZmix0ar7FGNRNWgReeskpaTSkH0SgL2U7WOl9r5cveR0yDWbbJYdfZHsOYTH5j3sgUkxm9WKMuhpQiNtvVjJrfBEy9Mr8JmJxAps82wmO9RL9l_1_OfwAhwYFj
CitedBy_id crossref_primary_10_17116_profmed20222511154
crossref_primary_10_1186_s12890_022_01911_5
crossref_primary_10_21518_2079_701X_2018_12_182_184
crossref_primary_10_1136_bmj_l5358
Cites_doi 10.1183/09031936.00137106
10.1056/NEJMoa021322
10.1164/rccm.2112043
10.2147/COPD.S71828
10.1136/thx.2006.060145
10.1182/blood-2005-10-4308
10.1016/S0140-6736(09)62084-5
10.1093/qjmed/hcl110
10.1164/ajrccm/145.6.1321
10.1378/chest.121.5.1434
10.1183/09031936.06.00143704
10.1378/chest.116.6.1632
10.1378/chest.93.3.580
10.1164/rccm.200510-1677OC
10.3109/15412555.2013.836171
10.1164/arrd.1986.133.1.14
10.1016/S0022-5223(99)70191-1
10.1136/thx.2005.040527
10.1164/ajrccm.160.6.9902115
10.1186/1741-7015-8-28
10.1097/00000421-198212000-00014
10.1378/chest.128.3.1201
10.1164/rccm.200507-1057OC
10.1111/crj.2014.8.issue-2
10.1164/ajrccm.152.3.7663812
10.1016/S0140-6736(09)61301-5
10.1378/chest.113.3.619
10.1016/S0140-6736(09)62083-3
10.3109/15412555.2013.808615
10.1016/j.rmed.2011.09.005
10.4193/Rhino11.051
10.1093/aje/kwg207
10.1164/ajrccm.154.4.8887592
10.1183/09031936.00096108
10.1001/archinternmed.2007.37
10.1016/S0885-3924(02)00690-5
10.1183/09031936.00189010
ContentType Journal Article
DBID CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
7X8
DOA
DOI 10.5507/bp.2016.030
DatabaseName Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
CrossRef
MEDLINE - Academic
Directory of Open Access Journals
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
CrossRef
MEDLINE - Academic
DatabaseTitleList
MEDLINE - Academic
MEDLINE
Database_xml – sequence: 1
  dbid: DOA
  name: Directory of Open Access Journals
  url: http://www.doaj.org/
  sourceTypes: Open Website
– sequence: 2
  dbid: ECM
  name: MEDLINE
  url: https://search.ebscohost.com/login.aspx?direct=true&db=cmedm&site=ehost-live
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Engineering
EISSN 1804-7521
EndPage 218
ExternalDocumentID oai_doaj_org_article_d7ebe694a62d4d0185a700324f6a2c39
10_5507_bp_2016_030
27364317
Genre Validation Studies
Journal Article
GroupedDBID -~X
2WC
36B
53G
ADBBV
ALMA_UNASSIGNED_HOLDINGS
BAWUL
C1A
CGR
CUY
CVF
DIK
EBD
ECM
EIF
EMB
EMOBN
EOJEC
F5P
GROUPED_DOAJ
GX1
ML~
NPM
OBODZ
OK1
SV3
TR2
AAYXX
CITATION
7X8
ID FETCH-LOGICAL-c392t-92ce4d7d974e112c7205a845372adde444d6ffd6df7d25a2458462c0be016b143
IEDL.DBID DOA
ISSN 1213-8118
IngestDate Tue Oct 22 15:12:42 EDT 2024
Fri Jun 28 16:29:00 EDT 2024
Fri Aug 23 03:22:55 EDT 2024
Thu May 23 23:23:59 EDT 2024
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 2
Keywords dyspnea
spirometry
prognosis
age
hemoglobin
COPD
Language English
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c392t-92ce4d7d974e112c7205a845372adde444d6ffd6df7d25a2458462c0be016b143
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
OpenAccessLink https://doaj.org/article/d7ebe694a62d4d0185a700324f6a2c39
PMID 27364317
PQID 1801431615
PQPubID 23479
PageCount 8
ParticipantIDs doaj_primary_oai_doaj_org_article_d7ebe694a62d4d0185a700324f6a2c39
proquest_miscellaneous_1801431615
crossref_primary_10_5507_bp_2016_030
pubmed_primary_27364317
PublicationCentury 2000
PublicationDate 2016-Jun
PublicationDateYYYYMMDD 2016-06-01
PublicationDate_xml – month: 06
  year: 2016
  text: 2016-Jun
PublicationDecade 2010
PublicationPlace Czech Republic
PublicationPlace_xml – name: Czech Republic
PublicationTitle Biomedical papers of the Medical Faculty of the University Palacký, Olomouc, Czechoslovakia
PublicationTitleAlternate Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub
PublicationYear 2016
Publisher Palacký University Olomouc, Faculty of Medicine and Dentistry
Publisher_xml – name: Palacký University Olomouc, Faculty of Medicine and Dentistry
References ref13
ref35
ref12
ref34
ref15
ref37
ref14
ref36
ref31
ref30
ref11
ref33
ref10
ref32
ref2
ref17
ref16
ref38
ref19
ref18
ref24
ref23
ref26
ref25
ref20
ref22
ref21
ref28
ref27
ref29
ref8
ref7
ref9
ref4
ref3
ref6
ref5
Global Strategy (ref0) 2014
References_xml – ident: ref35
  doi: 10.1183/09031936.00137106
– ident: ref3
  doi: 10.1056/NEJMoa021322
– ident: ref23
  doi: 10.1164/rccm.2112043
– ident: ref37
  doi: 10.2147/COPD.S71828
– ident: ref24
  doi: 10.1136/thx.2006.060145
– ident: ref36
  doi: 10.1182/blood-2005-10-4308
– ident: ref13
  doi: 10.1016/S0140-6736(09)62084-5
– volume-title: Global Initiative for Chronic Obstructive Lung Disease (GOLD
  year: 2014
  ident: ref0
  contributor:
    fullname: Global Strategy
– ident: ref5
  doi: 10.1093/qjmed/hcl110
– ident: ref21
  doi: 10.1164/ajrccm/145.6.1321
– ident: ref15
  doi: 10.1378/chest.121.5.1434
– ident: ref33
  doi: 10.1183/09031936.06.00143704
– ident: ref16
  doi: 10.1378/chest.116.6.1632
– ident: ref17
  doi: 10.1378/chest.93.3.580
– ident: ref20
  doi: 10.1164/rccm.200510-1677OC
– ident: ref10
  doi: 10.3109/15412555.2013.836171
– ident: ref2
  doi: 10.1164/arrd.1986.133.1.14
– ident: ref11
  doi: 10.1016/S0022-5223(99)70191-1
– ident: ref29
  doi: 10.1136/thx.2005.040527
– ident: ref27
  doi: 10.1164/ajrccm.160.6.9902115
– ident: ref6
  doi: 10.1186/1741-7015-8-28
– ident: ref26
  doi: 10.1097/00000421-198212000-00014
– ident: ref34
  doi: 10.1378/chest.128.3.1201
– ident: ref32
  doi: 10.1164/rccm.200507-1057OC
– ident: ref22
  doi: 10.1111/crj.2014.8.issue-2
– ident: ref30
  doi: 10.1164/ajrccm.152.3.7663812
– ident: ref4
  doi: 10.1016/S0140-6736(09)61301-5
– ident: ref18
  doi: 10.1378/chest.113.3.619
– ident: ref14
  doi: 10.1016/S0140-6736(09)62083-3
– ident: ref19
  doi: 10.3109/15412555.2013.808615
– ident: ref9
  doi: 10.1016/j.rmed.2011.09.005
– ident: ref38
  doi: 10.4193/Rhino11.051
– ident: ref25
  doi: 10.1093/aje/kwg207
– ident: ref28
  doi: 10.1164/ajrccm.154.4.8887592
– ident: ref31
  doi: 10.1183/09031936.00096108
– ident: ref7
  doi: 10.1001/archinternmed.2007.37
– ident: ref12
  doi: 10.1016/S0885-3924(02)00690-5
– ident: ref8
  doi: 10.1183/09031936.00189010
SSID ssj0062214
Score 2.1274815
Snippet The evaluation of chronic obstructive pulmonary disease (COPD) has been shifting from spirometry to focus on the patients' overall health. Despite the...
BACKGROUNDThe evaluation of chronic obstructive pulmonary disease (COPD) has been shifting from spirometry to focus on the patients' overall health. Despite...
Background: The evaluation of chronic obstructive pulmonary disease (COPD) has been shifting from spirometry to focus on the patients' overall health. Despite...
SourceID doaj
proquest
crossref
pubmed
SourceType Open Website
Aggregation Database
Index Database
StartPage 211
SubjectTerms age
Aged
copd
dyspnea
Dyspnea - mortality
Dyspnea - physiopathology
Female
Forced Expiratory Volume - physiology
hemoglobin
Hemoglobins - metabolism
Humans
Kaplan-Meier Estimate
Male
Middle Aged
Prognosis
Pulmonary Disease, Chronic Obstructive - mortality
Pulmonary Disease, Chronic Obstructive - physiopathology
Retrospective Studies
Severity of Illness Index
spirometry
Spirometry - methods
Surveys and Questionnaires
Walking - physiology
Title Chronic obstructive pulmonary disease prognostic score: A new index
URI https://www.ncbi.nlm.nih.gov/pubmed/27364317
https://search.proquest.com/docview/1801431615
https://doaj.org/article/d7ebe694a62d4d0185a700324f6a2c39
Volume 160
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrZ09T8MwEIYt6AQD4pvwJSN1NU0urp2wQWnViQWQ2CwntieUVpQi8e-5i9OqC2JhjaI4fs_yvZbPjxnrp77MLORBBKWkkEoGUfmiFLqooFDelhLo7PD0WT-9FY9jwuSsr_qimrCIB47CDZzGZlQprQInXYrpxWociSCDslDn8eheqlaLqTgHK4CW6k28MlGgh44n84jdNaiIUpmp27bweSMXtcj-331mm28m-2yvM4r8Pv7gAdvyzSHb3cAHHrFRR7bls6rDwH55Pl--48iyH9-823vhVILVzIjHzBcErbzj9xzNNG9BicfsdTJ-GU1FdymCwM7Cpyih9tJph-sAj16p1pAObSGHuQaaqqSUToXglAvawdAC7YMqqNPKY6crdEcnrNfMGn_GOCoLufK6UHWQdaYtoVgwp4UqSPx0lrD-Sh4zj-wLg2sGUtFUc0MqGlQxYQ8k3foVAla3DzCMpguj-SuMCbtZCW9wgNOuhW38bLkwGfFtcjKmCTuNEVk3hd5LkQM6_49fuGA71KVYB3bJehg4f8W2F2553Q6uH2DRz50
link.rule.ids 315,782,786,866,2106,27933,27934
linkProvider Directory of Open Access Journals
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Chronic+obstructive+pulmonary+disease+prognostic+score%3A+A+new+index&rft.jtitle=Biomedical+papers+of+the+Medical+Faculty+of+the+University+Palack%C3%BD%2C+Olomouc%2C+Czechoslovakia&rft.au=Horita%2C+Nobuyuki&rft.au=Koblizek%2C+Vladimir&rft.au=Plutinsky%2C+Marek&rft.au=Novotna%2C+Barbora&rft.date=2016-06-01&rft.issn=1213-8118&rft.volume=160&rft.issue=2&rft.spage=211&rft.epage=218&rft_id=info:doi/10.5507%2Fbp.2016.030&rft.externalDBID=NO_FULL_TEXT
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1213-8118&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1213-8118&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1213-8118&client=summon